Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration

Normal brain function depends on the interaction between highly specialized neurons that operate within anatomically and functionally distinct brain regions. Neuronal specification is driven by transcriptional programs that are established during early neuronal development and remain in place in the adult brain. The fidelity of neuronal specification depends on the robustness of the transcriptional program that supports the neuron type-specific gene expression patterns. Here we show that polycomb repressive complex 2 (PRC2), which supports neuron specification during differentiation, contributes to the suppression of a transcriptional program that is detrimental to adult neuron function and survival. We show that PRC2 deficiency in striatal neurons leads to the de-repression of selected, predominantly bivalent PRC2 target genes that are dominated by self-regulating transcription factors normally suppressed in these neurons. The transcriptional changes in PRC2-deficient neurons lead to progressive and fatal neurodegeneration in mice. Our results point to a key role of PRC2 in protecting neurons against degeneration.

[1]  Stuart L. Schreiber,et al.  Active genes are tri-methylated at K4 of histone H3 , 2002, Nature.

[2]  P. Arlotta,et al.  Neuronal subtype specification in the cerebral cortex , 2007, Nature Reviews Neuroscience.

[3]  H. Vinters,et al.  Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington’s disease , 2014, Science Translational Medicine.

[4]  A. Zantema,et al.  Cyclin D1 is an essential mediator of apoptotic neuronal cell death. , 1996, The EMBO journal.

[5]  P. Greengard,et al.  A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types , 2008, Cell.

[6]  Avi Ma'ayan,et al.  Network2Canvas: network visualization on a canvas with enrichment analysis , 2013, Bioinform..

[7]  V. Orlando Polycomb, Epigenomes, and Control of Cell Identity , 2003, Cell.

[8]  David J. Arenillas,et al.  oPOSSUM-3: Advanced Analysis of Regulatory Motif Over-Representation Across Genes or ChIP-Seq Datasets , 2012, G3: Genes | Genomes | Genetics.

[9]  Zhiping Weng,et al.  MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington's Disease Pathogenesis , 2014, PLoS genetics.

[10]  Martin Renqiang Min,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[11]  Murtaza Z Mogri,et al.  Cell Type–Specific Loss of BDNF Signaling Mimics Optogenetic Control of Cocaine Reward , 2010, Science.

[12]  K. Kroll,et al.  The roles and regulation of Polycomb complexes in neural development , 2014, Cell and Tissue Research.

[13]  Giovanni Coppola,et al.  Integrated genomics and proteomics to define huntingtin CAG length-dependent networks in HD Mice , 2016, Nature Neuroscience.

[14]  A. Sandelin,et al.  Identification of conserved regulatory elements by comparative genome analysis , 2003, Journal of biology.

[15]  Simon Kasif,et al.  Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains , 2008, PLoS genetics.

[16]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[17]  L. Alberi,et al.  Notch signaling in response to excitotoxicity induces neurodegeneration via erroneous cell cycle reentry , 2015, Cell Death and Differentiation.

[18]  A. Clark,et al.  Evolution of transcription factor binding sites in Mammalian gene regulatory regions: conservation and turnover. , 2002, Molecular biology and evolution.

[19]  R. J. Mullen,et al.  NeuN, a neuronal specific nuclear protein in vertebrates. , 1992, Development.

[20]  R. Simon,et al.  Transcriptional Response of Polycomb Group Genes to Status Epilepticus in Mice is Modified by Prior Exposure to Epileptic Preconditioning , 2015, Front. Neurol..

[21]  Michael B. Stadler,et al.  Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. , 2008, Molecular cell.

[22]  O. Elemento,et al.  Revealing global regulatory perturbations across human cancers. , 2009, Molecular cell.

[23]  S. Orkin,et al.  Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells , 2016, Cell.

[24]  M. MacDonald,et al.  Huntingtin facilitates polycomb repressive complex 2 , 2009, Human molecular genetics.

[25]  A. Tarakhovsky,et al.  Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation , 2015, The Journal of experimental medicine.

[26]  W. Markesbery,et al.  Wilms’ tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer’s disease , 2003, Brain Research.

[27]  M. Chesselet,et al.  Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. , 2001, Journal of neurophysiology.

[28]  Avi Ma'ayan,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[29]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[30]  Wyeth W. Wasserman,et al.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles , 2004, Nucleic Acids Res..

[31]  J. Bolam,et al.  Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[33]  S. Lowe,et al.  Control of apoptosis by p53 , 2003, Oncogene.

[34]  S. W. Davies,et al.  Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Z. Weng,et al.  The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington’s Disease , 2015, PloS one.

[36]  M. Chesselet,et al.  Mouse models of Huntington's disease. , 2002, Trends in pharmacological sciences.

[37]  H. Pasolli,et al.  EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. , 2011, Genes & development.

[38]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[39]  Jacqueline N. Crawley,et al.  What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice , 2000 .

[40]  S. Dunnett,et al.  Mouse Models of Huntington's Disease. , 2015, Current topics in behavioral neurosciences.

[41]  Paul Greengard,et al.  Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity , 2010, Science.

[42]  D. Reinberg,et al.  The Polycomb complex PRC2 and its mark in life , 2011, Nature.

[43]  P. Cole,et al.  LSD1 and the chemistry of histone demethylation. , 2007, Current opinion in chemical biology.

[44]  V. Warnault,et al.  Signaling , 2018, Modeling Strategic Behavior.

[45]  N. Jenkins,et al.  Highly restricted expression of Cre recombinase in cerebellar Purkinje cells , 2004, Genesis.

[46]  Z. Weng,et al.  The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington’s Disease , 2015, PloS one.

[47]  Allan R. Jones,et al.  Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.

[48]  P. Greengard,et al.  Resource Application of a Translational Profiling Approach for the Comparative Analysis of CNS Cell Types , 2009 .

[49]  A. Bird,et al.  Synthetic CpG islands reveal DNA sequence determinants of chromatin structure , 2014, eLife.

[50]  E. Nestler,et al.  G9a influences neuronal subtype specification in striatum , 2014, Nature Neuroscience.

[51]  P. Greengard,et al.  Cerebellar neurodegeneration in the absence of microRNAs , 2007, The Journal of experimental medicine.

[52]  Oliver Hobert,et al.  Regulation of terminal differentiation programs in the nervous system. , 2011, Annual review of cell and developmental biology.

[53]  Danny Reinberg,et al.  A double take on bivalent promoters. , 2013, Genes & development.

[54]  E. Fraenkel,et al.  Targeting H3K4 trimethylation in Huntington disease , 2013, Proceedings of the National Academy of Sciences.

[55]  Avi Ma'ayan,et al.  ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments , 2010, Bioinform..

[56]  Joshua L Plotkin,et al.  MicroRNA-128 Governs Neuronal Excitability and Motor Behavior in Mice , 2013, Science.

[57]  C. Nislow,et al.  Mammalian homologues of the Polycomb‐group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S.cerevisiae telomeres , 1997, The EMBO journal.

[58]  Z. Weng,et al.  RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression , 2015, PloS one.

[59]  Eric B Kmiec,et al.  DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates , 2009, Journal of neuroscience research.

[60]  P. Greengard,et al.  Control of Cognition and Adaptive Behavior by the GLP/G9a Epigenetic Suppressor Complex , 2009, Neuron.

[61]  N. Heintz,et al.  The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.

[62]  Mirang Kim,et al.  Vitamin C Facilitates Dopamine Neuron Differentiation in Fetal Midbrain Through TET1‐ and JMJD3‐Dependent Epigenetic Control Manner , 2015, Stem cells.

[63]  J A Duerre,et al.  IN VIVO METHYLATION AND TURNOVER OF RAT BRAIN HISTONES , 1974, Journal of neurochemistry.

[64]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[65]  Deanna L. Wallace,et al.  CREB regulation of nucleus accumbens excitability mediates social isolation–induced behavioral deficits , 2009, Nature Neuroscience.

[66]  Bradley E. Bernstein,et al.  GC-Rich Sequence Elements Recruit PRC2 in Mammalian ES Cells , 2010, PLoS genetics.

[67]  D. Reinberg,et al.  Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. , 2008, Molecular cell.

[68]  D. Reinberg,et al.  Nascent RNA interaction keeps PRC2 activity poised and in check , 2014, Genes & development.

[69]  D. Reinberg,et al.  An AUTS2–Polycomb complex activates gene expression in the CNS , 2014, Nature.

[70]  M. Chesselet,et al.  Electrophysiological and Morphological Changes in Striatal Spiny Neurons in R 6 / 2 Huntington ’ s Disease Transgenic Mice , 2001 .

[71]  T. Swigut,et al.  H3K27 Demethylases, at Long Last , 2007, Cell.

[72]  J. Yates,et al.  Extremely Long-Lived Nuclear Pore Proteins in the Rat Brain , 2012, Science.

[73]  O. Hobert,et al.  Maintenance of postmitotic neuronal cell identity , 2014, Nature Neuroscience.

[74]  S. Humbert,et al.  Phosphorylation of Huntingtin by Cyclin-Dependent Kinase 5 Is Induced by DNA Damage and Regulates Wild-Type and Mutant Huntingtin Toxicity in Neurons , 2007, The Journal of Neuroscience.

[75]  C. Dotti,et al.  Neuronal activity controls Bdnf expression via Polycomb de-repression and CREB/CBP/JMJD3 activation in mature neurons , 2016, Nature Communications.

[76]  T. Lemberger,et al.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation. , 2001, Genesis.

[77]  G. Fisone,et al.  Dopamine Signaling Leads to Loss of Polycomb Repression and Aberrant Gene Activation in Experimental Parkinsonism , 2014, PLoS genetics.

[78]  R. B. Redmon,et al.  Identity , 2021, Notre Dame J. Formal Log..

[79]  Michael E Talkowski,et al.  Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. , 2015, Human molecular genetics.

[80]  A. Tarakhovsky,et al.  Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice , 2015, The Journal of experimental medicine.

[81]  Christoph Wülfing,et al.  Polycomb Group Protein Ezh2 Controls Actin Polymerization and Cell Signaling , 2005, Cell.

[82]  Karl Herrup,et al.  EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia , 2013, Nature Neuroscience.